My road to Damascus: How i converted to the prohormone theory and the proprotein convertases

Biochemistry and Cell Biology

Volumn 90, Issue 6, 2012, Pages 750-768

  Chrétien, Michel ^a,b,c,d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Endoproteolysis; Pro opio melanocortin; Prohormones; Proprotein convertases

Indexed keywords

ACTIVATION MECHANISMS; BACTERIAL TOXIN; BIOLOGICAL FUNCTIONS; CELLULAR PROCESS; CLINICAL SKILLS; CONVERTASES; ENDOPROTEOLYSIS; ENDOPROTEOLYTIC CLEAVAGE; EXTRACELLULAR MATRIX PROTEIN; NEUROPEPTIDES; NEUROTROPHINS; PEPTIDE HORMONES; PLASMA CHOLESTEROL; PRO-OPIO-MELANOCORTIN; PROHORMONES; SERENDIPITOUS DISCOVERY;

CHOLESTEROL; HORMONES; TRANSCRIPTION FACTORS;

PEPTIDES;

ANGIOTENSIN II; BACTERIAL TOXIN; BETA ENDORPHIN; BETA INTERMEDIN; BETA LIPOTROPIN; BETA SECRETASE; CALCITONIN; COMPLEMENTARY DNA; CORTICOTROPIN; FURIN; GLUCAGON; GROWTH FACTOR; HEPCIDIN; HORMONE PRECURSOR; HUMAN GROWTH HORMONE; KEXIN; MESSENGER RNA; NEUROPEPTIDE; NEUROTROPHIN; PARATHYROID HORMONE; PEPTIDE HORMONE; PROENKEPHALIN; PROINSULIN; PROOPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; SCLEROPROTEIN; SUBTILISIN; TRANSCRIPTION FACTOR; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CELL FUNCTION; CHEMICAL REACTION; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DNA SEQUENCE; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; GENE MUTATION; HOMOLOGOUS RECOMBINATION; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; HYPOPHYSIS TUMOR; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

CANADA; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PEPTIDE HORMONES; PROPROTEIN CONVERTASES; PROTEIN PRECURSORS; SERINE ENDOPEPTIDASES;

BACTERIA (MICROORGANISMS);

EID: 84866928259     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o2012-031     Document Type: Article

References (136)

1. Abifadel M. Varret M. Rabes J.P. Allard D. Ouguerram K. Devillers M. et al. 2003. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34 (2): 154-156. 10.1038/ng1161 12730697
2. Abifadel M. Rabès J.-P. Jambart S. Halaby G. Gannagé-Yared M.-H. Sarkis A. et al. 2009. The molecular basis of familial hypercholesterolemia in Lebanon: Spectrum of LDLR mutations and role of PCSK9 as a modifier gene. Hum. Mutat. 30 (7): E682-E691. 10.1002/humu.21002 19319977
3. Basak A. Zhong M. Munzer J.S. Chrétien M. Seidah N.G. 2001. Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides. Biochem. J. 353 (3): 537-545. 10.1042/0264-6021:3530537 11171050
4. Basak A. Chrétien M. Seidah N.G. 2002. A rapid fluorometric assay for the proteolytic activity of SKI-1/S1P based on the surface glycoprotein of the hemorrhagic fever Lassa virus. FEBS Lett. 514 (2-3): 333-339. 10.1016/S0014-5793(02)02394-3 11943176
5. Basak A. Mitra A. Basak S. Pasko C. Chrétien M. Seaton P. 2007. A fluorogenic peptide containing the processing site of human SARS corona virus S-protein: kinetic evaluation and NMR structure elucidation. ChemBioChem, 8 (9): 1029-1037. 10.1002/cbic.200700007 17471479
6. Basak A. Chen A. Majumdar S. Smith H.P. 2011. In vitro assay for protease activity of proprotein convertase subtilisin kexins (PCSKs): an overall review of existing and new methodologies. Methods Mol. Biol. 768: 127-153. 10.1007/978-1-61779-204-5-6 21805240
7. Benjannet S. Seidah N.G. Routhier R. Chrétien M. 1980. A novel human pituitary peptide containing the gamma-MSH sequence. Nature, 285 (5764): 415-416. 10.1038/285415a0 7189826
8. Benjannet S. Rondeau N. Day R. Chrétien M. Seidah N.G. 1991. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc. Natl. Acad. Sci. U.S.A. 88 (9): 3564-3568. 10.1073/pnas.88.9.3564 2023902
9. Benjannet S. Rhainds D. Essalmani R. Mayne J. Wickham L. Jin W. et al. 2004. NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J. Biol. Chem. 279 (47): 48865-48875. 10.1074/jbc.M409699200 15358785
10. Bergeron E. Vincent M.J. Wickham L. Hamelin J. Basak A. Nichol S.T. et al. 2005. Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus. Biochem. Biophys. Res. Commun. 326 (3): 554-563. 10.1016/j.bbrc.2004.11.063 15596135
11. Bertagna X. Lis M. Gilardeau C. Chrétien M. 1974. Biosynthèse " In Vitro " de l'Hormone Béta-Lipotropique de Boeuf. Can. J. Biochem. 52 (5): 349-358. 10.1139/o74-053 4366173
12. Birk Y. Li C.H. 1964. Isolation and properties of a new, biologically active peptide from sheep pituitary glands. J. Biol. Chem. 239: 1048-1052. 14165906
13. Biron P. Chrétien M. Koiw E. Genest J. 1962. Effects of angiotensin infusions on aldosterone and electrolyte excretion in normal subjects and patients with hypertension and adrenocortical disorders. BMJ, 1 (5292): 1569-1575. 10.1136/bmj.1.5292.1569 13869448
14. Brown M.S. Goldstein J.L. 1999. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. U.S.A. 96 (20): 11041-11048. 10.1073/pnas.96.20.11041 10500120
15. Brown M.S. Goldstein J.L. 2006. Biomedicine. Lowering LDL-not only how low, but how long? Science, 311 (5768): 1721-1723. 10.1126/science.1125884 16556829
16. Chance R.E. Ellis R.M. Bromer W.W. 1968. Porcine proinsulin: characterization and amino acid sequence. Science, 161 (3837): 165-167. 10.1126/science.161.3837.165 5657063
17. Cheng D. Espenshade P.J. Slaughter C.A. Jaen J.C. Brown M.S. Goldstein J.L. 1999. Secreted site-1 protease cleaves peptides corresponding to luminal loop of sterol regulatory element-binding proteins. J. Biol. Chem. 274 (32): 22805-22812. 10.1074/jbc.274.32.22805 10428865
18. Chrétien, M. 1962. Angiotensin blood levels in humans. M.Sc. thesis, McGill University.
19. Chrétien M. 1988. L'expression génétique des neuropeptides; nouvelle chimie du cerveau. La Vie des Sciences 5 (1): 15-24.
20. Chrétien M. Gilardeau C. 1970. Effects of glacial acetic acid on the extraction, chemical stability, and biological activities of beta-LPH. Can. J. Biochem. 48 (4): 511-516. 10.1139/o70-082 4192532
21. Chrétien M. Li C.H. 1967 a. Purification and chemical characterization of γ-lipotropic hormone from sheep pituitary glands. Can. Med. Assoc. J. 96: 342.
22. Chrétien M. Li C.H. 1967 b. Isolation, purification, and characterization of gamma-lipotropic hormone from sheep pituitary glands. Can. J. Biochem. 45 (7): 1163-1174. 10.1139/o67-133 6035976
23. Chrétien M. Lis M. Gilardeau C. Benjannet S. 1976 a. In vitro biosynthesis of gamma-lipotropic hormone. Can. J. Biochem. 54 (6): 566-570. 10.1139/o76-083 1276982
24. Chrétien M. Benjannet S. Dragon N. Seidah N.G. Lis M. 1976 b. Isolation of peptides with opiate activity from sheep and human pituitaries: relationship to beta-lipotropin. Biochem. Biophys. Res. Commun. 72 (2): 472-478. 10.1016/S0006-291X(76)80066-6 985493
25. Chrétien M. Benjannet S. Gossard F. Gianoulakis C. Crine P. Lis M. Seidah N.G. 1979. From beta-lipotropin to beta-endorphin and 'pro-opio-melanocortin'. Can. J. Biochem. 57 (9): 1111-1121. 10.1139/o79-143 228824
26. Chrétien M. Mbikay M. Gaspar L. Seidah N.G. 1995. Proprotein convertases and the pathophysiology of human diseases: prospective considerations. Proc. Assoc. Am. Physicians, 107 (1): 47-66. 8630744
27. Chrétien M. Seidah N.G. Basak A. Mbikay M. 2008. Proprotein convertases as therapeutic targets. Expert Opin. Ther. Targets, 12 (10): 1289-1300. 10.1517/14728222.12.10.1289 18781827
28. Chretien M. Sikstrom R.A. Lazure C. Mbikay M. Seidah N.G. 1989. Functional diversity of bioactive peptides in the nervous system itself: "How the brain may understand". Biosci. Rep. 9 (6): 693-700.
29. Cohen J.C. Boerwinkle E. Mosley Jr T.H. Hobbs H.H. 2006. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354 (12): 1264-1272. 10.1056/NEJMoa054013 16554528
30. Craig L.C. Golumbic C. Mighton H. Titus E. 1945. Identification of small amounts of organic compounds by distribution studies; the use of buffers in counter-current distribution. J. Biol. Chem. 161: 321-332. 21005739
31. Creemers J.W. Khatib A.M. 2008. Knock-out mouse models of proprotein convertases: unique functions or redundancy? Front. Biosci. 13 (13): 4960-4971. 10.2741/3055 18508561
32. Crine P. Benjannet S. Seidah N.G. Lis M. Chrétien M. 1977 a. In vitro biosynthesis of beta-endorphin in pituitary glands. Proc. Natl. Acad. Sci. U.S.A. 74 (4): 1403-1406. 10.1073/pnas.74.4.1403 266182
33. Crine P. Benjannet S. Seidah N.G. Lis M. Chrétien M. 1977 b. In vitro biosynthesis of beta-endorphin, gamma-lipoprotein, and beta-lipotropin by the pars intermedia of beef pituitary glands. Proc. Natl. Acad. Sci. U.S.A. 74 (10): 4276-4280. 10.1073/pnas.74.10.4276 270671
34. Crine P. Gianoulakis C. Seidah N.G. Gossard F. Pezalla P.D. Lis M. Chrétien M. 1978. Biosynthesis of beta-endorphin from beta-lipotropin and a larger molecular weight precursor in rat pars intermedia. Proc. Natl. Acad. Sci. U.S.A. 75 (10): 4719-4723. 10.1073/pnas.75.10.4719 216997
35. Crine P. Gossard F. Seidah N.G. Blanchette L. Lis M. Chrétien M. 1979. Concomitant synthesis of beta-endorphin and alpha-melanotropin from two forms of pro-opiomelanocortin in the rat pars intermedia. Proc. Natl. Acad. Sci. U.S.A. 76 (10): 5085-5089. 10.1073/pnas.76.10.5085 228277
36. Cromlish J.A. Seidah N.G. Chrétien M. 1985. Isolation and characterization of four proteases from porcine pituitary neurointermediate lobes: relationship to the maturation enzyme of prohormones. Neuropeptides, 5 (4-6): 493-496. 10.1016/0143-4179(85)90062-9 3889696
37. Cromlish J.A. Seidah N.G. Chrétien M. 1986 a. Selective cleavage of human ACTH, beta-lipotropin, and the N-terminal glycopeptide at pairs of basic residues by IRCM-serine protease 1. Subcellular localization in small and large vesicles. J. Biol. Chem. 261 (23): 10859-10870. 3015945
38. Cromlish J.A. Seidah N.G. Chrétien M. 1986 b. A novel serine protease (IRCM-serine protease 1) from porcine neurointermediate and anterior pituitary lobes. Isolation, polypeptide chain structure, inhibitor sensitivity, and substrate specificity with fluorogenic peptide substrates. J. Biol. Chem. 261 (23): 10850-10858. 3525555
39. Cromlish J.A. Seidah N.G. Marcinkiewicz M. Hamelin J. Johnson D.A. Chrétien M. 1987. Human pituitary tryptase: molecular forms, NH2-terminal sequence, immunocytochemical localization, and specificity with prohormone and fluorogenic substrates. J. Biol. Chem. 262 (3): 1363-1373. 3543004
40. Davignon J. Roy M. 1993. Familial hypercholesterolemia in French Canadians: taking advantage of the presence of a "founder effect." Am. J. Cardiol. 72 (10): 6D-10D. 10.1016/0002-9149(93)90003-U 8213499
41. Davignon J. Dubuc G. Seidah N.G. 2010. The influence of PCSK9 polymorphisms on serum low-density lipoprotein cholesterol and risk of atherosclerosis. Curr. Atheroscler. Rep. 12 (5): 308-315. 10.1007/s11883-010- 0123-6 20623344
42. Denis N. Palmer-Smith H. Elisma F. Busuttil A. Wright T.G. Bou Khalil M. et al. 2011. Quantitative proteomic analysis of PCSK9 gain of function in human hepatic HuH7 cells. J. Proteome Res. 10 (4): 2011-2026. 10.1021/pr2000072 21332221
43. Desranleau R. Gilardeau C. Chrétien M. 1972. Radioimmunoassay of ovine beta-lipotropic hormone. Endocrinology, 91 (4): 1004-1010. 10.1210/endo-91-4-1004 4340603
44. Dessy C. Herlant M. Chrétien M. 1973. [Detection of lipotropin-synthesizing cells by the fluorescent antibody technic]. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D, 276 (3): 335-338. 4351683
45. Douglass J. Civelli O. Herbert E. 1984. Polyprotein gene expression: generation of diversity of neuroendocrine peptides. Annu. Rev. Biochem. 53 (1): 665-715. 10.1146/annurev.bi.53.070184.003313 6383203
46. Dubuc G. Chamberland A. Wassef H. Davignon J. Seidah N.G. Bernier L. Prat A. 2004. Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol, 24 (8): 1454-1459. 10.1161/01.ATV.0000134621.14315.43 15178557
47. Dubuc G. Tremblay M. Pare G. Jacques H. Hamelin J. Benjannet S. et al. 2010. A new method for measurement of total plasma PSCK9: clinical applications. J. Lipid Res. 51 (1): 140-149. 10.1194/jlr.M900273-JLR200 19571328
48. Dupuy A. Lindberg I. Zhou Y. Akil H. Lazure C. Chrétien M. et al. 1994. Processing of prodynorphin by the prohormone convertase PC1 results in high molecular weight intermediate forms: cleavage at a single arginine residue. FEBS Lett. 337 (1): 60-65. 10.1016/0014-5793(94)80630-6 8276115
49. Eipper B.A. Mains R.E. 1975. High molecular weight forms of adrenocorticotropic hormone in the mouse pituitary and in a mouse pituitary tumor cell line. Biochemistry, 14 (17): 3836-3844. 10.1021/bi00688a016 169885
50. Espenshade P.J. Cheng D. Goldstein J.L. Brown M.S. 1999. Autocatalytic processing of site-1 protease removes propeptide and permits cleavage of sterol regulatory element-binding proteins. J. Biol. Chem. 274 (32): 22795-22804. 10.1074/jbc.274.32.22795 10428864
51. Farooqi I.S. Volders K. Stanhope R. Heuschkel R. White A. Lank E. et al. 2007. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. J. Clin. Endocrinol. Metab. 92 (9): 3369-3373. 10.1210/jc.2007-0687 17595246
52. Fuller R.S. Brake A.J. Thorner J. 1989. Intracellular targeting and structural conservation of a prohormone-processing endoprotease. Science, 246 (4929): 482-486. 10.1126/science.2683070 2683070
53. Furth J. Chrétien M. Lis M. Belanger A. Moy P. Grauman J. 1975. Multipotent lipotropic hormones. In search of a pituitary cell producing multipotent LPH. Arch. Pathol. 99 (11): 572-581. 179514
54. Furuta M. Yano H. Zhou A. Rouille Y. Holst J.J. Carroll R. et al. 1997. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc. Natl. Acad. Sci. U.S.A. 94 (13): 6646-6651. 10.1073/pnas.94.13.6646 9192619
55. Gagnon J. Mayne J. Mbikay M. Woulfe J. Chrétien M. 2009. Expression of PCSK1 (PC1/3), PCSK2 (PC2) and PCSK3 (furin) in mouse small intestine. Regul. Pept. 152 (1-3): 54-60. 10.1016/j.regpep.2008.07.006 18706454
56. Gagnon J. Mayne J. Chen A. Raymond A. Woulfe J. Mbikay M. Chrétien M. 2011. PCSK2-null mice exhibit delayed intestinal motility, reduced refeeding response and altered plasma levels of several regulatory peptides. Life Sci. 88 (5-6): 212-217. 10.1016/j.lfs.2010.11.010 21092739
57. Genest J. Boucher R. De Champlain J. Veyrat R. Chrétien M. Biron P. et al. 1964. Studies on the Renin-Angiotensin System in Hypertensive Patients. Can. Med. Assoc. J. 90: 263-268. 14111732
58. Geschwind I.I. Li C.H. Barnafi L. 1957. The Structure of the β-Melanocyte-stimulating Hormone. J. Am. Chem. Soc. 79 (3): 620-625. 10.1021/ja01560a030
59. Gianoulakis C. Seidah N.G. Routhier R. Chrétien M. 1979. Biosynthesis and characterization of adrenocorticotropic hormone, alpha-melanocyte-stimulating hormone, and an NH2-terminal fragment of the adrenocorticotropic hormone/beta-lipotropin precursor from rat pars intermedia. J. Biol. Chem. 254 (23): 11903-11906. 227883
60. Goldstein J.L. 1986. On the origin and prevention of PAIDS (Paralyzed Academic Investigator's Disease Syndrome). J. Clin. Invest. 78 (3): 848-854. 10.1172/JCI112652 3528221
61. Guillemin R. 1978. Peptides in the brain: the new endocrinology of the neuron. Science, 202 (4366): 390-402. 10.1126/science.212832 212832
62. Herbert E. Uhler M. 1982. Biosynthesis of polyprotein precursors to regulatory peptides. Cell, 30 (1): 1-2. 10.1016/0092-8674(82)90002-2 6290073
63. Ho Y. Gruhler A. Heilbut A. Bader G.D. Moore L. Adams S.L. et al. 2002. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature, 415 (6868): 180-183. 10.1038/415180a 11805837
64. Hobbs H.H. Brown M.S. Russell D.W. Davignon J. Goldstein J.L. 1987. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N. Engl. J. Med. 317 (12): 734-737. 10.1056/NEJM198709173171204 3627182
65. Horton J.D. Cohen J.C. Hobbs H.H. 2009. PCSK9: a convertase that coordinates LDL catabolism. J. Lipid Res. 50 (Suppl.): S172-S177. 10.1194/jlr.R800091-JLR200 19020338
66. Hughes J. Smith T.W. Kosterlitz H.W. Fothergill L.A. Morgan B.A. Morris H.R. 1975. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature, 258 (5536): 577-579. 10.1038/258577a0 1207728
67. Jackson R.S. Creemers J.W. Ohagi S. Raffin-Sanson M.L. Sanders L. Montague C.T. et al. 1997. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16 (3): 303-306. 10.1038/ng0797-303 9207799
68. Jackson R.S. Creemers J.W. Farooqi I.S. Raffin-Sanson M.L. Varro A. Dockray G.J. et al. 2003. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J. Clin. Invest. 112 (10): 1550-1560. 14617756
69. LaBella F. Queen G. Senyshyn J. Lis M. Chrétien M. 1977. Lipotropin: localization by radioimmunoassay of endorphin precursors in pituitary and brain. Biochem. Biophys. Res. Commun. 75 (2): 350-357. 10.1016/0006-291X(77)91049-X 851442
70. Lazarus L.H. Ling N. Guillemin R. 1976. beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. Proc. Natl. Acad. Sci. U.S.A. 73 (6): 2156-2159. 10.1073/pnas.73.6.2156 1064883
71. Lazure C. Seidah N.G. Pélaprat D. Chrétien M. 1983. Proteases and posttranslational processing of prohormones: a review. Can. J. Biochem. Cell Biol. 61 (7): 501-515. 10.1139/o83-066 6354396
72. Leigh S.E. Leren T.P. Humphries S.E. 2009. Commentary PCSK9 variants: A new database. Atherosclerosis, 203 (1): 32-33. 10.1016/j.atherosclerosis.2009. 02.006 19249440
73. Leitersdorf E. Tobin E.J. Davignon J. Hobbs H.H. 1990. Common low-density lipoprotein receptor mutations in the French Canadian population. J. Clin. Invest. 85 (4): 1014-1023. 10.1172/JCI114531 2318961
74. Lernmark A. Chan S.J. Choy R. Nathans A. Carroll R. Tager H.S. et al. 1976. Biosynthesis of insulin and glucagon: a view of the current state of the art. Ciba Found. Symp. 41: 7-30. 780079
75. Li C.H. 1964. Lipotropin, a new active peptide from pituitary gands. Nature, 201 (4922): 924. 10.1038/201924a0 14132790
76. Li C.H. Barnafi L. Chrétien M. Chung D. 1965. Isolation and amino-acid sequence of beta-LPH from sheep pituitary glands. Nature, 208 (5015): 1093-1094. 10.1038/2081093b0 4162144
77. Li C.H. Dixon J.S. Chung D. 1958. The structure of bovine corticotropins. J. Am. Chem. Soc. 80 (10): 2587-2588. 10.1021/ja01543a061
78. Li C.H. Dixon J.S. Chung D. 1961. Adrenocorticotropins. XXI. The amino acid sequence of bovine adrenocorticotropin. Biochim. Biophys. Acta, 46: 324-334. 13761812
79. Lissitzky J.-C. Luis J. Munzer J.S. Benjannet S. Parat F. Chrétien M. et al. 2000. Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7. Biochem. J. 346 (1): 133-138. 10.1042/0264-6021:3460133 10657249
80. Long C.N. 1956. Pituitary-adrenal relationships. Annu. Rev. Physiol. 18 (1): 409-432. 10.1146/annurev.ph.18.030156.002205 13355224
81. Ma Y.H. Betard C. Roy M. Davignon J. Kessling A.M. 1989. Identification of a second "French Canadian" LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin. Genet. 36 (4): 219-228. 2805380
82. Mains R.E. Eipper B.A. Ling N. 1977. Common precursor to corticotropins and endorphins. Proc. Natl. Acad. Sci. U.S.A. 74 (7): 3014-3018. 10.1073/pnas.74.7.3014 197529
83. Mattei M.G. Mbikay M. Sylla B.S. Lenoir G. Mattei J.F. Seidah N.G. Chrétien M. 1990. Assignment of the gene for neuroendocrine protein 7B2 (SGNE1 locus) to mouse chromosome region 2[E3-F3] and to human chromosome region 15q11-q15. Genomics, 6 (3): 436-440. 10.1016/0888-7543(90)90473-8 2328988
84. Maxwell K.N. Breslow J.L. 2004. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc. Natl. Acad. Sci. U.S.A. 101 (18): 7100-7105. 10.1073/pnas.0402133101 15118091
85. Mayne J. Raymond A. Chaplin A. Cousins M. Kaefer N. Gyamera-Acheampong C. et al. 2007. Plasma PCSK9 levels correlate with cholesterol in men but not in women. Biochem. Biophys. Res. Commun. 361 (2): 451-456. 10.1016/j.bbrc.2007.07. 029 17645871
86. Mayne J. Dewpura T. Raymond A. Bernier L. Cousins M. Ooi T.C. et al. 2011. Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell Culture. Clin. Chem. 57 (10): 1415-1423. 10.1373/clinchem. 2011.165191 21813713
87. Mbikay, M., and Seidah, N.G. 2011. Proprotein Convertases. In Methods in Molecular Biology. Edited by J.W. Walker. Humana Press, New York. pp. 367.
88. Mbikay M. Seidah N.G. Chrétien M. Simpson E.M. 1995. Chromosomal assignment of the genes for proprotein convertases PC4, PC5, and PACE 4 in mouse and human. Genomics, 26 (1): 123-129. 10.1016/0888-7543(95)80090-9 7782070
89. Mbikay M. Tadros H. Ishida N. Lerner C.P. De Lamirande E. Chen A. et al. 1997. Impaired fertility in mice deficient for the testicular germ-cell protease PC4. Proc. Natl. Acad. Sci. U.S.A. 94 (13): 6842-6846. 10.1073/pnas.94.13.6842 9192653
90. Mullis K. Faloona F. Scharf S. Saiki R. Horn G. Erlich H. 1986. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb. Symp. Quant. Biol. 51 (1): 263-273. 10.1101/SQB.1986.051.01.032 3472723
91. Nakanishi S. Inoue A. Kita T. Nakamura M. Chang A.C.Y. Cohen S.N. Numa S. 1979. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta- lipotropin precursor. Nature, 278 (5703): 423-427. 10.1038/278423a0 221818
92. O'Donnell C.J. Nabel E.G. 2011. Genomics of cardiovascular disease. N. Engl. J. Med. 365 (22): 2098-2109. 10.1056/NEJMra1105239 22129254
93. O'Rahilly S. Gray H. Humphreys P.J. Krook A. Polonsky K.S. White A. et al. 1995. Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N. Engl. J. Med. 333 (21): 1386-1391. 10.1056/NEJM199511233332104 7477119
94. Ozden S. Lucas-Hourani M. Ceccaldi P.E. Basak A. Valentine M. Benjannet S. et al. 2008. Inhibition of chikungunya virus infection in cultured human muscle cells by furin inhibitors: Impairment of the maturation of the E2 surface glycoprotein. J. Biol. Chem. 283 (32): 21899-21908. 10.1074/jbc.M802444200 18559340
95. Paquet L. Bergeron F. Boudreault A. Seidah N.G. Chrétien M. Mbikay M. Lazure C. 1994. The neuroendocrine precursor 7B2 is a sulfated protein proteolytically processed by a ubiquitous furin-like convertase. J. Biol. Chem. 269 (30): 19279-19285. 8034690
96. Pelletier G. Leclerc R. Labrie F. Cote J. Chrétien M. Lis M. 1977. Immunohistochemical localization of beta-lipotropic hormone in the pituitary gland. Endocrinology, 100 (3): 770-776. 10.1210/endo-100-3-770 401361
97. Potts Jr. J.T. Keutmann H.T. Niall H.D. Tregear G.W. 1971. The chemistry of parathyroid hormone and the calcitonins. Vitam. Horm. 29: 41-93. 10.1016/S0083-6729(08)60047-3 4944057
98. Rawson R.B. DeBose-Boyd R. Goldstein J.L. Brown M.S. 1999. Failure to cleave sterol regulatory element-binding proteins (SREBPs) causes cholesterol auxotrophy in Chinese hamster ovary cells with genetic absence of SREBP cleavage-activating protein. J. Biol. Chem. 274 (40): 28549-28556. 10.1074/jbc.274.40.28549 10497220
99. Robert, A. 1946. Mémorial des actes de l'Association canado-américaine, accompagné d'une narration des principaux événements auxquels elle a été mêlée depuis 50 ans. L'Avenir National, Manchester NH.
100. Roberts J.L. Herbert E. 1977 a. Characterization of a common precursor to corticotropin and beta-lipotropin: cell-free synthesis of the precursor and identification of corticotropin peptides in the molecule. Proc. Natl. Acad. Sci. U.S.A. 74 (11): 4826-4830. 10.1073/pnas.74.11.4826 200934
101. Roberts J.L. Herbert E. 1977 b. Characterization of a common precursor to corticotropin and beta-lipotropin: identification of beta-lipotropin peptides and their arrangement relative to corticotropin in the precursor synthesized in a cell-free system. Proc. Natl. Acad. Sci. U.S.A. 74 (12): 5300-5304. 10.1073/pnas.74.12.5300 202948
102. Rougeon F. Kourilsky P. Mach B. 1975. Insertion of a rabbit beta-globin gene sequence into an E. coli plasmid. Nucleic Acids Res. 2 (12): 2365-2378. 10.1093/nar/2.12.2365 802513
103. Scamuffa N. Calvo F. Chrétien M. Seidah N.G. Khatib A.M. 2006. Proprotein convertases: lessons from knockouts. FASEB J. 20 (12): 1954-1963. 10.1096/fj.05-5491rev 17012247
104. Scamuffa N. Basak A. Lalou C. Wargnier A. Marcinkiewicz J. Siegfried G. et al. 2008. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7. Gut, 57 (11): 1573-1582. 10.1136/gut.2007.141812 18664504
105. Seidah N.G. 2009. PCSK9 as a therapeutic target of dyslipidemia. Expert Opin. Ther. Targets, 13 (1): 19-28. 10.1517/14728220802600715 19063703
106. Seidah N.G. 2011. The proprotein convertases, 20 years later. Methods Mol. Biol. 768: 23-57. 10.1007/978-1-61779-204-5-3 21805237
107. Seidah N.G. Chrétien M. 1999. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848 (1-2): 45-62. 10.1016/S0006-8993(99)01909-5 10701998
108. Seidah N.G. Prat A. 2012. The biology and therapeutic targeting of the proprotein convertases. Nat. Rev. Drug Discov. 11 (5): 367-383. 10.1038/nrd3699 22679642
109. Seidah N.G. Gianoulakis C. Crine P. Lis M. Benjannet S. Routhier R. Chrétien M. 1978. In vitro biosynthesis and chemical characterization of beta-lipotropin, gamma-lipotropin, and beta-endorphin in rat pars intermedia. Proc. Natl. Acad. Sci. U.S.A. 75 (7): 3153-3157. 10.1073/pnas.75.7.3153 277917
110. Seidah N.G. Cromlish J.A. Hamelin J. Thibault G. Chrétien M. 1986. Homologous IRCM-serine protease 1 from pituitary, heart atrium and ventricle: a common pro-hormone maturation enzyme? Biosci. Rep. 6 (9): 835-844. 10.1007/BF01117107 3028526
111. Seidah N.G. Ladenheim R. Mbikay M. Hamelin J. Lutfalla G. Rougeon F. et al. 1989. The cDNA structure of rat plasma kallikrein. DNA, 8 (8): 563-574. 10.1089/dna.1989.8.563 2598771
112. Seidah N.G. Gaspar L. Mion P. Marcinkiewicz M. Mbikay M. Chrétien M. 1990. cDNA sequence of two distinct pituitary proteins homologous to Kex2 and furin gene products: tissue-specific mRNAs encoding candidates for pro-hormone processing proteinases. DNA Cell Biol. 9 (6): 415-424. 10.1089/dna.1990.9.415 2169760
113. Seidah N.G. Benjannet S. Pareek S. Chrétien M. Murphy R.A. 1996 a. Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett. 379 (3): 247-250. 10.1016/0014-5793(95)01520-5 8603699
114. Seidah N.G. Benjannet S. Pareek S. Savaria D. Hamelin J. Goulet B. et al. 1996 b. Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem. J. 314 (3): 951-960. 8615794
115. Seidah N.G. Mowla S.J. Hamelin J. Mamarbachi A.M. Benjannet S. Touré B.B. et al. 1999. Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. Proc. Natl. Acad. Sci. U.S.A. 96 (4): 1321-1326. 10.1073/pnas.96.4.1321 9990022
116. Seidah N.G. Benjannet S. Wickham L. Marcinkiewicz J. Jasmin S.B. Stifani S. et al. 2003. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation. Proc. Natl. Acad. Sci. U.S.A. 100 (3): 928-933. 10.1073/pnas.0335507100 12552133
117. Siegfried G. Basak A. Cromlish J.A. Benjannet S. Marcinkiewicz J. Chrétien M. et al. 2003 a. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J. Clin. Invest. 111 (11): 1723-1732. 10.1172/JCI17220 12782675
118. Siegfried G. Khatib A.M. Benjannet S. Chrétien M. Seidah N.G. 2003 b. The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity. Cancer Res. 63 (7): 1458-1463. 12670890
119. Simon E.J. 1976. The opiate receptors. Neurochem. Res. 1 (1): 3-28. 10.1007/BF00965627
120. Smeekens S.P. Steiner D.F. 1990. Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2. J. Biol. Chem. 265 (6): 2997-3000. 2154467
121. Stawowy P. Blaschke F. Kilimnik A. Goetze S. Kallisch H. Chrétien M. et al. 2002. Proprotein convertase PC5 regulation by PDGF-BB involves PI3-kinase/p70(s6)-kinase activation in vascular smooth muscle cells. Hypertension, 39 (2): 399-404. 10.1161/hy0202.103000 11882580
122. Stawowy P. Kallisch H. Kilimnik A. Margeta C. Seidah N.G. Chrétien M. et al. 2004 a. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor. Biochem. Biophys. Res. Commun. 321 (3): 531-538. 10.1016/j.bbrc.2004.07.001 15358140
123. Stawowy P. Kallisch H. Veinot J.P. Kilimnik A. Prichett W. Goetze S. et al. 2004 b. Endoproteolytic activation of alpha(v) integrin by proprotein convertase PC5 is required for vascular smooth muscle cell adhesion to vitronectin and integrin-dependent signaling. Circulation, 109 (6): 770-776. 10.1161/01.CIR.0000112583.50762.DE 14970114
124. Stawowy P. Margeta C. Kallisch H. Seidah N.G. Chrétien M. Fleck E. Graf K. 2004 c. Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase. Cardiovasc. Res. 63 (1): 87-97. 10.1016/j.cardiores.2004.03.010 15194465
125. Steiner D.F. Oyer P.E. 1967. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc. Natl. Acad. Sci. U.S.A. 57 (2): 473-480. 10.1073/pnas.57.2.473 16591494
126. Steiner D.F. Cunningham D. Spigelman L. Aten B. 1967. Insulin biosynthesis: evidence for a precursor. Science, 157 (3789): 697-700. 10.1126/science.157.3789.697 4291105
127. Taylor N.A. Van De Ven W.J. Creemers J.W. 2003. Curbing activation: proprotein convertases in homeostasis and pathology. FASEB J. 17 (10): 1215-1227. 10.1096/fj.02-0831rev 12832286
128. Thomas G. 2002. Furin at the cutting edge: From protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3 (10): 753-766. 10.1038/nrm934 12360192
129. Tian R. Wang S. Elisma F. Li L. Zhou H. Wang L. Figeys D. 2011. Rare cell proteomic reactor applied to stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics study of human embryonic stem cell differentiation. Mol. Cell. Proteomics, 10 (2): 679. 10.1074/mcp.M110.000679 20530636
130. Touré B.B. Munzer J.S. Basak A. Benjannet S. Rochemont J. Lazure C. et al. 2000. Biosynthesis and enzymatic characterization of human SKI-1/S1P and the processing of its inhibitory prosegment. J. Biol. Chem. 275 (4): 2349-2358. 10.1074/jbc.275.4.2349 10644685
131. Vincent M.J. Sanchez A.J. Erickson B.R. Basak A. Chrétien M. Seidah N.G. Nichol S.T. 2003. Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. J. Virol. 77 (16): 8640-8649. 10.1128/JVI.77.16.8640-8649.2003 12885882
132. Vollenweider F. Benjannet S. Decroly E. Savaria D. Lazure C. Thomas G. et al. 1996. Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases. Biochem. J. 314 (2): 521-532. 8670066
133. Watson S.J. Seidah N.G. Chrétien M. 1982. The carboxy terminus of the precursor to vasopressin and neurophysin: immunocytochemistry in rat brain. Science, 217 (4562): 853-855. 10.1126/science.6125034 6125034
134. Wickham L. Benjannet S. Marcinkiewicz E. Chrétien M. Seidah N.G. 2005. beta-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI: binding partners processed by furin. J. Neurochem. 92 (1): 93-102. 10.1111/j.1471-4159.2004.02840.x 15606899
135. Yalow R.S. 1976. Multiple forms of corticotropin (adrenocorticotropic hormone, ACTH) and their significance. Ciba Found. Symp. 41: 159-181. 181223
136. Zaid A. Roubtsova A. Essalmani R. Marcinkiewicz J. Chamberland A. Hamelin J. et al. 2008. Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration. Hepatology, 48 (2): 646-654. 10.1002/hep.22354 18666258